摘要
慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)患病率高、死亡率高、致残率高、疾病负担重,是严重危害公众健康的重大慢性疾病。中医、西医诊疗COPD各有优势并在临床中广泛应用。为促进中西医结合诊疗COPD水平的提高,世界中医药学会联合会内科专业委员会组织成立了多学科背景的指南研制工作组,参考国际临床实践指南研制方法和流程,基于现有最佳证据,结合中西医结合治疗COPD特点并权衡干预措施的利弊,形成了中西医结合诊疗COPD的13条推荐意见,可供各级医疗机构的呼吸内科(中医、中西医结合、西医)医师诊疗时参考使用。
Chronic obstructive pulmonary disease(COPD), with high prevalence rate, mortality, and disability rate, and heavy burden caused by the disease, has become a major chronic disease seriously threatening public health worldwide. Chinese medicine and Western medicine both have advantages in diagnosing and treating COPD, which have been widely used in clinic. In order to improve the diagnostic and treatment level for COPD with integrated traditional Chinese and Western medicine, Chinese Medicine of internal Medicine Committee of World federation of Chinese Medicine Societies organized and established a multidisciplinary background working group, the document was formulated by referring to the formulating method and process of international guidelines in clinical practice, current evidence with the best quality, and characteristics of integrated traditional Chinese and Western medicine in treating COPD and weighing pros and cons of interventions, 13 recommendations were established, physicians can refer to this guideline to formulate individualized treatment plans in combination with the specific conditions of patients.
作者
世界中医药学会联合会内科专业委员会
李建生
余学庆
Internal Medicine Committee of World Federation of Chinese Medicine Societies Chinese Medicine Societies;LI Jiansheng
出处
《中国循证医学杂志》
CSCD
北大核心
2023年第10期1117-1128,共12页
Chinese Journal of Evidence-based Medicine
基金
国家重点研发计划专项课题(编号:2018YFC1704802)
国家中医药管理局中医药传承与创新“百千万”人才工程—岐黄工程首席科学家项目(编号:国中医药人教函[2020]219号)
国家中医药管理局国家中医药传承创新团队项目(编号:ZYYCXTD-C-202206)。
关键词
慢性阻塞性肺疾病
中西医结合
临床实践指南
Chronic obstructive pulmonary disease
Integrative medicine
Clinical practice guideline